drp
☆    

India,
2018-08-10 07:09
(900 d 13:16 ago)

Posting: # 19162
Views: 3,281
 

 Sampling time [Design Issues]

Dear All,
My query is how is Sampling time points and number of sampling decided in bioequivalence study.

Thanks and regards:
drp


Edit: Category changed; see also this post #1[Helmut]
Helmut
★★★
avatar
Homepage
Vienna, Austria,
2018-08-10 11:51
(900 d 08:33 ago)

@ drp
Posting: # 19165
Views: 2,788
 

 Sampling time

Hi drp,

you need to know the PK of the drug (distribution, elimination) and the properties of the formulation (absorption, lag-time). For some general approaches see here and there.

Dif-tor heh smusma 🖖
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes
Durga
☆    

India,
2018-08-14 07:37
(896 d 12:47 ago)

@ drp
Posting: # 19167
Views: 2,603
 

 Sampling time

We need to check the molecule available PK profile of drug (absorption, distribution and elimination). we need to read the guidelines how many sampling time points need to be set at different phases as per above mentioned.

you need to check the metabolite pharmacological activity (if applicable)

bases on the formulation also. it is also very important.


Edit: Full quote removed. Please delete everything from the text of the original poster which is not necessary in understanding your answer; see also this post #5. Please follow the Forum’s Policy[Helmut]
jag009
★★★

NJ,
2018-08-18 00:17
(892 d 20:07 ago)

@ Durga
Posting: # 19171
Views: 2,523
 

 Sampling time

» We need to check the molecule available PK profile of drug (absorption, distribution and elimination). we need to read the guidelines how many sampling time points need to be set at different phases as per above mentioned.

"Read the guidelines how many sampling time points needed"? What guidelines?

John
Activity
 Admin contact
21,315 posts in 4,446 threads, 1,489 registered users;
online 2 (0 registered, 2 guests [including 2 identified bots]).
Forum time: Tuesday 19:25 CET (Europe/Vienna)

Any one who considers arithmetical methods
of producing random digits is, of course,
in a state of sin.    John von Neumann

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5